"Apabetalone is in line to start any day now, whatever that means. Dr C's comments seem to add credibility to DM's comments and the Eversana partnership. They have had ample time to set this up properly. Let's get this trial going and this therapy authorized."

So would there be a reasonable explanation why an open-label study of  Apabetalone, in Covid 19 infection, Phase 1 trial, by now, is not on the COVID 19 therapeutics tracker?  

Koo